Nervgen Pharma Corp Stock Overlap Studies Parabolic SAR
| NGEN Stock | CAD 3.00 0.13 4.15% |
| Symbol |
The output start index for this execution was one with a total number of output elements of sixty. The Parabolic SAR indicator is used to determine the direction of NervGen Pharma Corp's momentum and the point in time when NervGen Pharma has higher than normal probability directional change.
NervGen Pharma Technical Analysis Modules
Most technical analysis of NervGen Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NervGen from various momentum indicators to cycle indicators. When you analyze NervGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NervGen Pharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NervGen Pharma Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of NervGen Pharma Corp based on widely used predictive technical indicators. In general, we focus on analyzing NervGen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NervGen Pharma's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of NervGen Pharma's intrinsic value. In addition to deriving basic predictive indicators for NervGen Pharma, we also check how macroeconomic factors affect NervGen Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2022 | 2023 | 2024 (projected) | Net Debt To EBITDA | 1.33 | 1.1 | 0.65 | 1.07 | Intangibles To Total Assets | 0.0264 | 0.0181 | 0.0393 | 0.0746 |
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Additional Tools for NervGen Stock Analysis
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.